1. Studies Coordinating Centre, Research Unit Hypertension and Cardiovascular Epidemiology, KU Leuven Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium;
2. Division of Cardiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium;
3. Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium;
4. Department of Nephrology, Grand Hôpital de Charleroi, Gilly, Belgium;
5. Division of Radiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium;
6. Division of Cardiology, University Hospitals Leuven, Leuven, Belgium;
7. Department of Cardiology, Oslo University Hospital Ullevål, Oslo, Norway;
8. Department of Cardiology, Grand Hôpital de Charleroi, Gilly, Belgium;
9. Department of Cardiology, Isala Hospital, Zwolle, The Netherlands;
10. Department of Forensic Toxicology, Institute of Legal Medicine, University of Frankfurt, Frankfurt, Germany;
11. Division of Cardiology, Department Internal Medicine, University Hospitals Leuven, Leuven, Belgium;
12. Centre for Molecular and Vascular Biology, Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium;
13. R&D Group VitaK, Maastricht University, Maastricht, The Netherlands